2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
CAS: 511296-88-1
Ref. 3D-FM43025
1g | A consultar | |
2g | A consultar | |
5g | A consultar | |
10g | A consultar | |
500mg | A consultar |
Información del producto
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide is a novel agent that has been shown to be effective in the treatment of non-small cell lung cancer. The mechanism of action involves inhibition of sirtuin (SIRT) enzymes and consequent induction of apoptosis in cancer cells. The drug also inhibits the production of mononucleotides that are essential for DNA synthesis and RNA transcription. 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide has been tested in clinical trials for the treatment of depression. This drug has also been shown to have muscle strengthening effects by increasing levels of creatine kinase and insulin like growth factor 1 (IGF-
Propiedades químicas
Consulta técnica sobre: 3D-FM43025 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.